Concentra Group Holdings Parent (CON) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Concentra Group Holdings Parent

NYSE•Healthcare•Medical Care Facilities

$36.37+0.75(0.02%)Pre-market

Market Cap

$4.44B

P/E

22.3x

P/S

1.9x

P/B

9.3x

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

How this company scores

GoodMetricSide Score: 68/100

Strongest: Profitability (25/25); weakest: Growth (9/25).

Profitability25/25

Growth9/25

Balance Sheet & Red Flags10/25

Cash & Earnings Quality24/25

Strengths

Rising free cash flowStrong marginsHigh ROECash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 22.3x5y range 13.0x – 22.3x

Currently above its 6-quarter median.

P/S · 1.9x5y range 1.0x – 1.9x

Currently above its 6-quarter median.

P/B · 9.3x5y range 1.9x – 9.7x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Leverage Risk

Red Flag

D/E ratio is 3.3 — heavily leveraged and vulnerable to rising rates or cash flow dips.

Share Dilution

Watch

Shares outstanding rose 3.6% — mild dilution. Compare to earnings growth to assess the net per-share impact.

Price & Volume

Market Cap $4.44B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.29B
Q. Revenue: $606.03M
TTM EBITDA: $454.56M
TTM Op. Income: $374.81M
Q. Op. Income: $115.07M
TTM Net Income: $198.73M
Q. Net Income: $65.30M
EPS: $0.51
Shares Out.: $125.10M

$2.29B in TTM revenue declined 7.5% YoY, reaching $606.03M last quarter. TTM EBITDA of $454.56M and TTM operating income of $374.81M show growth is flowing through to the bottom line. TTM net income of $198.73M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 31.7%
EBITDA Margin: 22.3%
Op. Margin: 19.0%
Net Margin: 10.8%

Op. margin of 19.0% is up 2.7% YoY — cost efficiency is improving. Net margin at 10.8% and gross margin of 31.7% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 22.3x
P/S Ratio: 1.9x
P/B Ratio: 9.3x

At 22.3x P/E, the stock trades within typical market levels. P/S of 1.9x and P/B of 9.3x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 70% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.01B
Cash: $158.04M
Long-Term Debt: $1.57B
Book Value: $477.10M
D/E Ratio: 3.3
Debt/EBITDA: 11.7

With $3.01B in assets and $1.57B in long-term debt, D/E is 3.3and book value is $477.10M — elevated leverage, meaning significant financial risk in a downturn. Across the last 8 quarters, debt/equity has fallen for 6 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $135.21M
TTM Free Cash Flow: $267.42M
FCF Margin: 11.7%
FCF / Net Income: 1.3

TTM FCF of $267.42M on $135.21M in operating cash flow. The FCF / Net Income ratio of 1.3x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 3 consecutive quarters — an improving trend.